WO2006030889A1 - リパーゼ粉末、その製造方法及びその使用 - Google Patents
リパーゼ粉末、その製造方法及びその使用 Download PDFInfo
- Publication number
- WO2006030889A1 WO2006030889A1 PCT/JP2005/017125 JP2005017125W WO2006030889A1 WO 2006030889 A1 WO2006030889 A1 WO 2006030889A1 JP 2005017125 W JP2005017125 W JP 2005017125W WO 2006030889 A1 WO2006030889 A1 WO 2006030889A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lipase
- powder
- aqueous solution
- carbon atoms
- lipase powder
- Prior art date
Links
- 108090001060 Lipase Proteins 0.000 title claims abstract description 122
- 102000004882 Lipase Human genes 0.000 title claims abstract description 121
- 239000004367 Lipase Substances 0.000 title claims abstract description 121
- 235000019421 lipase Nutrition 0.000 title claims abstract description 121
- 239000000843 powder Substances 0.000 title claims abstract description 54
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 33
- 239000000194 fatty acid Substances 0.000 claims abstract description 33
- 229930195729 fatty acid Natural products 0.000 claims abstract description 33
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 32
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 150000001298 alcohols Chemical class 0.000 claims abstract description 8
- 239000007864 aqueous solution Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 13
- -1 alcohol ester Chemical class 0.000 claims description 12
- 238000005886 esterification reaction Methods 0.000 claims description 11
- 230000032050 esterification Effects 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 150000002148 esters Chemical group 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical group OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 3
- 241000235395 Mucor Species 0.000 claims description 2
- 241000588986 Alcaligenes Species 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 235000019626 lipase activity Nutrition 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract 1
- 238000005809 transesterification reaction Methods 0.000 description 16
- 239000012528 membrane Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000007900 aqueous suspension Substances 0.000 description 10
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000012141 concentrate Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 241000588810 Alcaligenes sp. Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 229940093609 tricaprylin Drugs 0.000 description 3
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 125000005639 glycero group Chemical group 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000186073 Arthrobacter sp. Species 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000193464 Clostridium sp. Species 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000603729 Geotrichum sp. Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 241001558145 Mucor sp. Species 0.000 description 1
- 241000187681 Nocardia sp. Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 102100033357 Pancreatic lipase-related protein 2 Human genes 0.000 description 1
- 241000228168 Penicillium sp. Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000592823 Puccinia sp. Species 0.000 description 1
- 241000235402 Rhizomucor Species 0.000 description 1
- 241000952054 Rhizopus sp. Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001147693 Staphylococcus sp. Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 241001148118 Xanthomonas sp. Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000012051 hydrophobic carrier Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000001050 stape Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6454—Glycerides by esterification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6458—Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
Definitions
- the present invention relates to a lipase powder that can be suitably used for various esterification reactions, transesterification reactions, and the like, a production method thereof, an esterification method using the lipase powder, a transesterification method, and the like.
- Lipases are widely used in esterification reactions of various carboxylic acids such as fatty acids with alcohols such as monoalcohols and polyhydric alcohols, and transesterification reactions between a plurality of carboxylic acid esters. Of these, transesterification is an important technology for the production of various fatty acid esters, sugar esters and steroids, including the modification of animal and vegetable fats and oils.
- lipase an oil and fat hydrolase
- lipase as a catalyst is a natural product.
- the target product can be efficiently produced due to its substrate specificity and position specificity.
- lipase powder when used in the transesterification reaction as it is, the activity is not sufficiently exhibited, and it is difficult to uniformly disperse the originally water-soluble lipase in the oily raw material, and the recovery is difficult. is there.
- lipase is conventionally treated with some kind of carrier, for example, anion exchange resin (Patent Document 1), phenol adsorption resin (Patent Document 2), hydrophobic carrier (Patent Document 3), cation exchange resin (Patent Document). 4), chelating resin (Patent Document 5) and the like, and generally used for ester ester exchange reaction and the like.
- lipase is immobilized and used for transesterification.
- powerful immobilized lipase is not only accompanied by loss of original lipase activity due to the treatment of immobilized lipase.
- the pores were clogged with raw materials and products, and as a result, the transesterification rate was lowered.
- the water retained by the carrier is brought into the reaction system, so that side reactions such as the formation of diglycerides and monoglycerides in the transesterification of fats and oils should be avoided. It was difficult.
- lipase powder in the presence or absence of an inert organic solvent, the lipase is added to the ester-containing raw material so that 90% or more of the dispersed lipase powder particles are maintained at a particle size in the range of 1 to 100 ⁇ m during the transesterification reaction.
- a method of transesterifying by dispersing powder has been proposed (Patent Document 6). It has also been proposed to use an enzyme powder obtained by drying an enzyme solution containing phospholipids and fat-soluble vitamins (Patent Document 7).
- Patent Document 1 JP-A-60-98984
- Patent Document 2 Japanese Patent Laid-Open No. 61-202688
- Patent Document 3 JP-A-2-138986
- Patent Document 4 JP-A-3-61485
- Patent Document 5 Japanese Patent Laid-Open No. 1-262795
- Patent Document 6 Japanese Patent No. 2668187
- Patent Document 7 Japanese Unexamined Patent Publication No. 2000-106873
- An object of the present invention is to provide a lipase powder having improved lipase activity.
- Another object of the present invention is to provide a method for producing the above lipase powder. Another object of the present invention is to provide an esterification method and a transesterification method using the lipase powder.
- the present invention has been made based on the knowledge that when lipase is granulated using a medium chain fatty acid, an alcohol ester thereof, or a mixture thereof and powdered, the lipase activity is improved in each stage.
- the present invention provides a lipase powder characterized by comprising a lipase and a granulated product containing at least one selected from a fatty acid having 8 to 12 carbon atoms, an alcohol ester thereof, and a mixture thereof. provide.
- the present invention also provides a fatty acid having 8 to 12 carbon atoms, an alcohol thereof, in a lipase-containing aqueous solution.
- the present invention provides a method for producing a lipase powder characterized in that at least one selected from esters and their mixture is added and spray-dried or freeze-dried.
- the present invention also provides a lipase for esterification or transesterification containing the lipase powder.
- the present invention also provides a method for esterification or transesterification of fatty acid and alcohol, characterized by using the above lipase.
- lipase used in the present invention examples include lipoprotein lipase, monoacyl daricello lipase, diacyl glycero lipase, triacinole glycero lipase, galacto lipase, and phospho lipase. Of these, triacyldaricerolipase is preferred.
- the microorganisms that produce these lipases are not particularly limited to bacteria, yeasts, filamentous fungi, actinomycetes, etc., but include genus Pseudomonas (Psudomonas sp.), Genus Alcaligenes sp. Arthrobacter sp.), Staphyl ococcus sp.
- Chromobacterum sp. Chromobacterum sp., Xanthomonas sp., Lactobacillus sp., Clostridium sp., Candida sp., Geotrichum sp., Sacch romycopsis sp., Nocardia sp., Fuzanum spj, "7 Spenoreginoles ( Aspergillus sp.), Penicillium sp., Mucor sp., Rhizopus sp., Phycomycese sp., Puccinia sp., Notinoles Genus (Bacillus sp.), Streptomyces (Streptmycese sp.) And the like.
- 1,3-specific lipase is preferred, in particular, 1,3-specific lipase derived from the genus Mucor and Alkaligenes is preferable, and Rhizomu cor miehei and Alkagenes belonging to the genus Mucoyl are more preferable. 1,3-specific lipase derived from Alcaligenes sp.
- Fatty acids having 8 to 12 carbon atoms used for granulating lipase in the present invention include saturated, Any of saturated, straight chain and branched chain fatty acids can be used. Of these, saturated fatty acids are preferred, more preferably fatty acids having 8 to 10 carbon atoms, particularly saturated fatty acids having 8 or 10 carbon atoms. These can be used alone or in combination of two or more. A part of the fatty acid may form a salt with an alkali metal or alkaline earth metal. Of these, sodium and potassium form a salt with the alkali metal, and you should! /.
- Examples of the alcohol ester include esters of the above fatty acids with various alcohols such as monoalcohols, polyhydric alcohols, and mixtures thereof.
- examples of the alcohol include glycols such as ethylene glycol, propylene glycol, and butylene glycol, glycerin, erythritol, pentaerythritol, and trimethylol bread.
- partial esters having at least one alcoholic hydroxyl group are preferred.
- monoglycerides and diglycerides are preferred, and monoglycerides are particularly preferred. These can be used alone or in combination of two or more.
- the above fatty acid and its alcohol ester can be used in combination.
- the ratio of lipase and fatty acids is various ratios. Force that can be used It is preferably 0.1 to 20 times the amount of lipase mass, and more preferably 1 to 20 times the amount.
- Lipase powder of the present invention is preferably the water content is not more than 10 wt% instrument particularly, 6. and even preferably at 5 to 8.5 mass 0/0! /,.
- the particle size of the lipase powder of the present invention can be arbitrary, but it is preferable that 90% by mass or more of the lipase powder has a particle size of 1 to 100 / ⁇ ⁇ .
- the particle size of the lipase powder is preferably spherical.
- the particle size of the lipase powder can be measured, for example, using a particle size distribution measuring device (LA-500) manufactured by HORIBA.
- LA-500 particle size distribution measuring device manufactured by HORIBA.
- the lipase powder of the present invention can be obtained, for example, by adding a fatty acid or the like to a lipase-containing aqueous solution, followed by spray drying or freeze drying.
- the lipase-containing aqueous solution includes a lipase culture solution from which bacterial cells have been removed, a purified culture solution, a lipase powder obtained from these dissolved and dispersed again in water, a commercially available lipase.
- examples thereof include those obtained by dissolving and dispersing the powder again in water and commercially available liquid lipases.
- those obtained by removing low-molecular components such as salts in order to further increase the lipase activity are more preferred, and those obtained by removing low-molecular components such as sugars are more preferred in order to further enhance the powder properties.
- lipase culture solution examples include soybean flour, peptone, corn “stape” liquor, K H
- soy flour 0.1 to 20 wt% preferably from 1.0 to 10 wt%, peptone 0.1 to 30 mass 0/0, preferably from 0.5 to 10 weight 0/0, corn ' Suthep 'liquor from 0.1 to 30 weight 0/0, preferably rather is from 0.5 to 10 weight 0/0, ⁇ ⁇ 0. 01 ⁇ 20 mass 0/0, preferably from 0.1 to 5 mass 0/0
- soy flour 0.1 to 20 wt% preferably from 1.0 to 10 wt%, peptone 0.1 to 30 mass 0/0, preferably from 0.5 to 10 weight 0/0, corn ' Suthep 'liquor from 0.1 to 30 weight 0/0, preferably rather is from 0.5 to 10 weight 0/0, ⁇ ⁇ 0. 01 ⁇ 20 mass 0/0, preferably from 0.1 to 5 mass 0/0
- peptone 0.1 to 30 mass 0/0 preferably from 0.5 to 10 weight 0/0
- ⁇ ⁇ is 0.01 to 20% by mass, preferably 0.05 to 5% by mass.
- the culture conditions are the culture temperature
- UF membrane treatment Specifically, by performing the UF membrane treatment, concentrating the aqueous solution containing lipase to a volume of 1Z2 and then adding the same amount of phosphate buffer as the concentrate, it is repeated 1 to 5 times. A lipase-containing aqueous solution from which low-molecular components have been removed can be obtained.
- Centrifugation is preferably performed at 200 to 20,000 Xg, and membrane filtration is preferably performed at a pressure of 3.0 kg / m 2 or less with an MF membrane or a filter press.
- the homogenizer has a stirring speed of 500 to 30,000 rpm, preferably ⁇ is 1,000 to 15,000 rpm, and the speed of the waging blender is 500 to 10,000 rpm, preferably ⁇ is 1,000 to 5, OOOrpm. is there.
- the stirring time is 0.5 to 10 minutes, preferably 1 to 5 minutes.
- the ultrasonic crushing is performed under conditions of 1 to 50 KHz, preferably 10 to 20 KHz.
- the ball mill should use glass balls with a diameter of 0.1 to 0.5 mm. In the present invention, it is preferable to use a lipase-containing aqueous solution containing 5 to 30% by mass as a solid content.
- the amount of fatty acid to be added is preferably 0.1 to 20 times the solid mass of the lipase-containing aqueous solution, and more preferably 0.3 to 10 times. A volume of ⁇ 5 times is most preferred.
- the solid content concentration in the lipase-containing aqueous solution can be determined as Brix.% Using, for example, a saccharimeter (BRX-242, manufactured by Shiichi 'IS Co., Ltd.).
- the pH of the lipase-containing aqueous solution is adjusted to 10 or less, preferably 6 to: LO.
- the pH adjustment is preferably performed immediately before the drying step such as spray drying, but the lipase is added in advance so that the pH immediately before the drying step, which may be performed in any of the previous steps, is within the above range.
- the pH of the aqueous solution may be adjusted.
- alkali metal hydroxides such as sodium hydroxide, which can use various alkaline agents and acids! /.
- the concentration method is not particularly limited, but evaporator, flash evaporator, UF membrane concentration, MF membrane concentration, salting out with inorganic salts, solvent precipitation method, ion exchange cellulose adsorption method, water-absorbing gel, etc. And the water absorption method.
- UF membrane concentration and evaporator are used.
- the UF membrane concentration module is a flat membrane or hollow fiber membrane with a molecular weight cut off of 3,000 to 000, preferably ⁇ 6,000 to 50,000, and the material is positive acrylic-tolyl, polysulfone, etc. Is preferred.
- the spray drying may be performed using, for example, a spray dryer such as a nozzle countercurrent type, a disk countercurrent type, a nozzle cocurrent type, or a disk cocurrent type.
- a spray dryer such as a nozzle countercurrent type, a disk countercurrent type, a nozzle cocurrent type, or a disk cocurrent type.
- the atomizer rotation speed is preferably 4,000 to 20,000 rpm, and the calorific heat has an inlet temperature of 100 to 200. It is preferable to perform spray drying by controlling at C, outlet temperature of 40 to 100 ° C.
- Freeze-drying is also preferable. For example, it is preferably performed by a lab-size small-scale freeze-dryer or shelf-type freeze-drying. Further, it can be prepared by drying under reduced pressure.
- the lipase is a 1,3-specific lipase, in particular when the lipase is derived from Rhizomucor miehei or Alcalig enes sp.
- the 1,3-selectivity is very high according to the present invention.
- the lipase powder can be suitably used as a transesterification lipase. Then, this lipase powder can be used to efficiently carry out a transesterification reaction of fats and oils by a conventional method.
- esterification can be performed using the powder lipase composition of the present invention.
- examples of the compound having at least one alcoholic hydroxyl group in the molecule as a target for esterification include various compounds such as various monoalcohols, polyhydric alcohols, and amino alcohols. Specific examples include polyhydric alcohols such as short chain, medium chain, and long chain saturated, unsaturated, linear, branched alcohol, glycols, glycerin, and erythritols. Of these, glycerin is preferred.
- examples of the carboxylic acid include short chain, medium chain, and long chain saturated, unsaturated, linear, and branched carboxylic acids.
- fatty acids having 6 to 30 carbon atoms such as octanoic acid, decanoic acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid and the like can be mentioned. These can be used alone or in combination of two or more.
- unsaturated fatty acids are preferred, and conjugated linoleic acid is particularly preferred.
- the esterification conditions are the same as those described in, for example, JP-A Nos. 13-169795 and 15-113396.
- 0.1 to 2% by mass of the powder lipase composition of the present invention is added to the total mass of the substrate, that is, the total mass of the compound having an alcoholic hydroxyl group and the carboxylic acid, and 30 to 60 ° C. It is better to react for 24 to 72 hours. At this time, it is preferable to carry out the reaction while reducing the pressure of the reaction system and removing water generated by esterification.
- Rhizomucor miehe oil-borne liquid lipase (trade name Palatase) manufactured by Novo Nordisk in a form in which lipase is dissolved and dispersed in an aqueous solution, using UF module (SIP-0013 manufactured by Asahi Kasei Kogyo Co., Ltd.) Remove lipase-containing aqueous solution 1 (solid content 20 1 mass
- liquid lipase (paratase) was treated with a UF membrane under ice-cooling, concentrated to a volume of 1/2, and then added with 0.01 M phosphate buffer having the same amount of pH 7 as the concentrated liquid. In the same manner, the operation of adding a phosphate buffer after UF membrane treatment was repeated twice for the obtained solution, and further UF membrane treatment was performed. The resulting lipase concentrate was designated as Lipase-containing aqueous solution 1.
- This liquid is sprayed using a spray dryer (SD-1000 type: manufactured by Tokyo Rika Kikai Co., Ltd.) under the conditions of an inlet temperature of 130 ° C, a dry air amount of 0.7 to 1. lmVmin, and a spraying pressure of ll to 12 kpa.
- a lipase powder was obtained.
- the shape of the lipase powder particles was spherical, and 90% by mass or more of the lipase powder was in the range of particle size 1 to: LOO ⁇ m, and the average particle size was 7.6 ⁇ m.
- the particle size was measured using a particle size distribution measuring apparatus (LA-500) manufactured by HORIBA.
- the solid content concentration in the lipase-containing aqueous solution was determined as Brix.% Using a saccharimeter (BRX-242 manufactured by CIS Co., Ltd.).
- Fatty acid aqueous suspension (5 mass% aqueous suspension of n-decanoic acid (C10FA)) was used instead of fatty acid monoglyceride aqueous suspension (3 mass% aqueous suspension of n-decanoic acid) Obtained lipase powder in the same manner as in Example 1.
- Lipase concentrate A lipase powder was obtained in the same manner as in Example 1 except that 0.01 M phosphate buffer of PH7 was used at a volume ratio of 1: 1.
- the lipase activity of the lipase powder thus obtained was measured by the following method. The results are shown in Table 1.
- Powder lipase is added to oil mixed with triolein and tricaprylin at a ratio of 1: 1 (w).
- the reaction was performed at 60 ° C.
- a sample of 101 was sampled over time, diluted with 1.5 ml of hexane, and the solution obtained by filtering the powder lipase was used as a gas chromatograph sample.
- the reaction rate was calculated from the following equation after gas chromatography (column: DB-lht).
- the gas chromatographic conditions are: column temperature: initial 150 ° C, temperature increase 15 ° C / min, final 370 ° C. Other conditions are the same as in the 1.3-selectivity test below.
- Reaction rate (%) ⁇ C34 area / (C24 area + C34 area) ⁇ X 100
- C24 indicates tricaprylin
- C34 indicates that one fatty acid of tricaprylin is replaced with 18, and area is the area of those areas.
- the reaction rate constant K value was obtained by analysis software (Orijin ver.6.1).
- the lipase activity was expressed as a relative activity when the threshold value of Comparative Example 1 was 100.
- suspension 1 (5 wt% aqueous suspension of n-octanoic acid (C8FA)
- suspension 2 5 wt% aqueous suspension of n-decanoic acid (C10FA)
- suspension 3 5% by mass aqueous suspension of n-dodecanoic acid (C12FA)
- a lipase powder was obtained in the same manner as in Example 2.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005800313147A CN101023167B (zh) | 2004-09-16 | 2005-09-16 | 脂肪酶粉末、其制备方法及其使用 |
AT05783308T ATE555195T1 (de) | 2004-09-16 | 2005-09-16 | Lipasepulver, verfahren zur herstellung davon und verwendung davon |
EP05783308A EP1795591B1 (en) | 2004-09-16 | 2005-09-16 | Lipase powder, method for producing same and use thereof |
CA2580259A CA2580259C (en) | 2004-09-16 | 2005-09-16 | Lipase powder, method for manufacture thereof, and use thereof |
DK05783308.9T DK1795591T3 (da) | 2004-09-16 | 2005-09-16 | Lipasepulver, fremgangsmåde til fremstilling af samme og anvendelse deraf |
US11/716,580 US8580550B2 (en) | 2004-09-16 | 2007-03-12 | Lipase powder, method for manufacture thereof, and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-269976 | 2004-09-16 | ||
JP2004269976A JP4478540B2 (ja) | 2004-09-16 | 2004-09-16 | リパーゼ粉末、その製造方法及びその使用 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/716,580 Continuation US8580550B2 (en) | 2004-09-16 | 2007-03-12 | Lipase powder, method for manufacture thereof, and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006030889A1 true WO2006030889A1 (ja) | 2006-03-23 |
Family
ID=36060136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/017125 WO2006030889A1 (ja) | 2004-09-16 | 2005-09-16 | リパーゼ粉末、その製造方法及びその使用 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8580550B2 (ja) |
EP (1) | EP1795591B1 (ja) |
JP (1) | JP4478540B2 (ja) |
KR (1) | KR101267920B1 (ja) |
CN (1) | CN101023167B (ja) |
AT (1) | ATE555195T1 (ja) |
CA (1) | CA2580259C (ja) |
DK (1) | DK1795591T3 (ja) |
MY (1) | MY147776A (ja) |
TW (1) | TWI403583B (ja) |
WO (1) | WO2006030889A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008114656A1 (ja) * | 2007-03-16 | 2008-09-25 | The Nisshin Oillio Group, Ltd. | リパーゼ粉末製剤、その製造方法及び使用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2186886B8 (en) * | 2005-01-19 | 2013-06-12 | The Nisshin OilliO Group, Ltd. | Process for production of purified lipase |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61202688A (ja) | 1985-02-27 | 1986-09-08 | ノボ ノルディスク アクティーゼルスカブ | 固定化リパーゼ調製品の製造方法 |
JPH01262795A (ja) | 1988-04-11 | 1989-10-19 | Kao Corp | 固定化酵素の製造方法 |
JPH02138986A (ja) | 1987-12-22 | 1990-05-28 | Unilever Nv | 脂肪酸エステルの製造方法 |
JPH0361485A (ja) | 1989-07-31 | 1991-03-18 | Ajinomoto Co Inc | 固定化リパーゼ酵素剤 |
JPH04234985A (ja) * | 1990-12-18 | 1992-08-24 | Shin Nippon Kagaku Kogyo Kk | 無粉塵酵素粉末を製造する方法 |
JP2668187B2 (ja) | 1993-09-17 | 1997-10-27 | 日清製油株式会社 | リパーゼ粉末を用いたエステル交換法 |
JPH10204494A (ja) * | 1997-01-27 | 1998-08-04 | Kao Corp | 粉末状酵素製剤及びそれを用いた造粒物 |
JP2000106873A (ja) | 1998-10-06 | 2000-04-18 | Nisshin Oil Mills Ltd:The | 熱安定性酵素およびその製造法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK402583D0 (da) * | 1983-09-05 | 1983-09-05 | Novo Industri As | Fremgangsmade til fremstilling af et immobiliseret lipasepraeparat og anvendelse deraf |
DE3886412T2 (de) * | 1987-09-28 | 1994-05-11 | Novo Nordisk As | Verfahren zur immobilisierung von lipasen. |
US5288619A (en) * | 1989-12-18 | 1994-02-22 | Kraft General Foods, Inc. | Enzymatic method for preparing transesterified oils |
JPH05345900A (ja) * | 1991-07-08 | 1993-12-27 | Fuji Oil Co Ltd | 硬質油脂の製造法 |
US6495357B1 (en) * | 1995-07-14 | 2002-12-17 | Novozyme A/S | Lipolytic enzymes |
US5902738A (en) * | 1996-04-18 | 1999-05-11 | Roche Vitamins Inc. | Enzymatic acylation |
CN1073625C (zh) * | 1999-05-28 | 2001-10-24 | 无锡轻工大学 | 脂肪酶固相催化油脂甘油解工艺 |
AU2001293671A1 (en) * | 2000-09-25 | 2002-01-08 | Novozymes A/S | Methods for processing crustacean material |
US20030054509A1 (en) * | 2001-04-06 | 2003-03-20 | Archer-Daniels-Midland Company | Method for producing fats or oils |
AU2003283952A1 (en) * | 2002-08-16 | 2004-03-03 | Novozymes North America, Inc. | Process for enzymatic hydrolysis of cyclic oligomers |
-
2004
- 2004-09-16 JP JP2004269976A patent/JP4478540B2/ja active Active
-
2005
- 2005-09-16 CA CA2580259A patent/CA2580259C/en not_active Expired - Fee Related
- 2005-09-16 EP EP05783308A patent/EP1795591B1/en not_active Not-in-force
- 2005-09-16 CN CN2005800313147A patent/CN101023167B/zh not_active Expired - Fee Related
- 2005-09-16 DK DK05783308.9T patent/DK1795591T3/da active
- 2005-09-16 MY MYPI20054347A patent/MY147776A/en unknown
- 2005-09-16 AT AT05783308T patent/ATE555195T1/de active
- 2005-09-16 KR KR1020077008582A patent/KR101267920B1/ko not_active IP Right Cessation
- 2005-09-16 TW TW094132152A patent/TWI403583B/zh not_active IP Right Cessation
- 2005-09-16 WO PCT/JP2005/017125 patent/WO2006030889A1/ja active Application Filing
-
2007
- 2007-03-12 US US11/716,580 patent/US8580550B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61202688A (ja) | 1985-02-27 | 1986-09-08 | ノボ ノルディスク アクティーゼルスカブ | 固定化リパーゼ調製品の製造方法 |
JPH02138986A (ja) | 1987-12-22 | 1990-05-28 | Unilever Nv | 脂肪酸エステルの製造方法 |
JPH01262795A (ja) | 1988-04-11 | 1989-10-19 | Kao Corp | 固定化酵素の製造方法 |
JPH0361485A (ja) | 1989-07-31 | 1991-03-18 | Ajinomoto Co Inc | 固定化リパーゼ酵素剤 |
JPH04234985A (ja) * | 1990-12-18 | 1992-08-24 | Shin Nippon Kagaku Kogyo Kk | 無粉塵酵素粉末を製造する方法 |
JP2668187B2 (ja) | 1993-09-17 | 1997-10-27 | 日清製油株式会社 | リパーゼ粉末を用いたエステル交換法 |
JPH10204494A (ja) * | 1997-01-27 | 1998-08-04 | Kao Corp | 粉末状酵素製剤及びそれを用いた造粒物 |
JP2000106873A (ja) | 1998-10-06 | 2000-04-18 | Nisshin Oil Mills Ltd:The | 熱安定性酵素およびその製造法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008114656A1 (ja) * | 2007-03-16 | 2008-09-25 | The Nisshin Oillio Group, Ltd. | リパーゼ粉末製剤、その製造方法及び使用 |
RU2447148C2 (ru) * | 2007-03-16 | 2012-04-10 | Дзе Ниссин Ойллио Груп, Лтд. | Порошкообразный препарат липазы, способ его получения и применения |
JP5145609B2 (ja) * | 2007-03-16 | 2013-02-20 | 日清オイリオグループ株式会社 | リパーゼ粉末製剤、その製造方法及び使用 |
AU2008227690B2 (en) * | 2007-03-16 | 2013-09-05 | The Nisshin Oillio Group, Ltd. | Powdery lipase preparation, method for producing the same and use thereof |
US8921081B2 (en) | 2007-03-16 | 2014-12-30 | The Nisshin Oillio Group, Ltd. | Powdery lipase preparation, method for producing the same and use thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2006081473A (ja) | 2006-03-30 |
TWI403583B (zh) | 2013-08-01 |
ATE555195T1 (de) | 2012-05-15 |
DK1795591T3 (da) | 2012-05-29 |
MY147776A (en) | 2013-01-31 |
EP1795591B1 (en) | 2012-04-25 |
CA2580259A1 (en) | 2006-03-23 |
US8580550B2 (en) | 2013-11-12 |
CN101023167B (zh) | 2010-05-05 |
CN101023167A (zh) | 2007-08-22 |
EP1795591A4 (en) | 2008-12-17 |
KR20070057949A (ko) | 2007-06-07 |
US20070155003A1 (en) | 2007-07-05 |
JP4478540B2 (ja) | 2010-06-09 |
CA2580259C (en) | 2013-08-06 |
TW200617167A (en) | 2006-06-01 |
EP1795591A1 (en) | 2007-06-13 |
KR101267920B1 (ko) | 2013-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4828418B2 (ja) | リパーゼ粉末、その製造方法及びその使用 | |
JP4394598B2 (ja) | リパーゼ粉末組成物及びそれを用いたエステル化物の製造方法 | |
JP5145609B2 (ja) | リパーゼ粉末製剤、その製造方法及び使用 | |
WO2005097985A1 (ja) | 1,3-特異性リパーゼ粉末、その製造方法及びその使用 | |
JP5728335B2 (ja) | エステル交換油脂の製造方法及びその装置 | |
JPWO2006077860A1 (ja) | 精製リパーゼの製造方法 | |
WO2006030889A1 (ja) | リパーゼ粉末、その製造方法及びその使用 | |
JP2007068426A (ja) | リパーゼ粉末製剤、その製造方法及び使用 | |
WO2011068076A1 (ja) | リパーゼ粉末製剤及びその使用 | |
JP5258941B2 (ja) | リパーゼ活性の回復方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11716580 Country of ref document: US Ref document number: 2580259 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005783308 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580031314.7 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077008582 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2005783308 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11716580 Country of ref document: US |